GENETIC AND ENVIRONMENTAL MODULATION OF LOW-DENSITY-LIPOPROTEIN CATABOLISM

[1] AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917

[2] AUSTIN MA, 1986, LANCET, V2, P592

[3] A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J]. SCIENCE, 1986, 232 (4746) : 34 - 47

[4] ANTIATHEROGENIC EFFECT OF PROBUCOL UNRELATED TO ITS HYPOCHOLESTEROLEMIC EFFECT - EVIDENCE THAT ANTIOXIDANTS INVIVO CAN SELECTIVELY INHIBIT LOW-DENSITY-LIPOPROTEIN DEGRADATION IN MACROPHAGE-RICH FATTY STREAKS AND SLOW THE PROGRESSION OF ATHEROSCLEROSIS IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) : 7725 - 7729

[5] DAVIGNON J, 1989, ARTERIOSCLEROSIS DAL, V8, P1

[6] VERY LOW-DENSITY LIPOPROTEIN APOLIPOPROTEIN-B METABOLISM IN HUMANS [J]. KLINISCHE WOCHENSCHRIFT, 1988, 66 (16): : 703 - 712

[7] DENKE MA, 1988, J LIPID RES, V29, P963

[8] HETEROGENEITY OF PLASMA LOW-DENSITY LIPOPROTEINS MANIFESTATIONS OF THE PHYSIOLOGIC PHENOMENON IN MAN [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1983, 32 (03): : 283 - 291

[9] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) : 1237 - 1245

[10] DNA POLYMORPHISMS OF THE APOLIPOPROTEIN GENES - THEIR USE IN THE INVESTIGATION OF THE GENETIC COMPONENT OF HYPERLIPEMIA AND ATHEROSCLEROSIS [J]. ATHEROSCLEROSIS, 1988, 72 (2-3) : 89 - 108

[1] AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917

[2] AUSTIN MA, 1986, LANCET, V2, P592

[3] A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J]. SCIENCE, 1986, 232 (4746) : 34 - 47

[4] ANTIATHEROGENIC EFFECT OF PROBUCOL UNRELATED TO ITS HYPOCHOLESTEROLEMIC EFFECT - EVIDENCE THAT ANTIOXIDANTS INVIVO CAN SELECTIVELY INHIBIT LOW-DENSITY-LIPOPROTEIN DEGRADATION IN MACROPHAGE-RICH FATTY STREAKS AND SLOW THE PROGRESSION OF ATHEROSCLEROSIS IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) : 7725 - 7729

[5] DAVIGNON J, 1989, ARTERIOSCLEROSIS DAL, V8, P1

[6] VERY LOW-DENSITY LIPOPROTEIN APOLIPOPROTEIN-B METABOLISM IN HUMANS [J]. KLINISCHE WOCHENSCHRIFT, 1988, 66 (16): : 703 - 712

[7] DENKE MA, 1988, J LIPID RES, V29, P963

[8] HETEROGENEITY OF PLASMA LOW-DENSITY LIPOPROTEINS MANIFESTATIONS OF THE PHYSIOLOGIC PHENOMENON IN MAN [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1983, 32 (03): : 283 - 291

[9] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) : 1237 - 1245

[10] DNA POLYMORPHISMS OF THE APOLIPOPROTEIN GENES - THEIR USE IN THE INVESTIGATION OF THE GENETIC COMPONENT OF HYPERLIPEMIA AND ATHEROSCLEROSIS [J]. ATHEROSCLEROSIS, 1988, 72 (2-3) : 89 - 108